SE437832B - Forfarande for framstellning av 3,7-disubstituerade-3-cefem-4-karboxylsyraforeningar - Google Patents
Forfarande for framstellning av 3,7-disubstituerade-3-cefem-4-karboxylsyraforeningarInfo
- Publication number
- SE437832B SE437832B SE7702547A SE7702547A SE437832B SE 437832 B SE437832 B SE 437832B SE 7702547 A SE7702547 A SE 7702547A SE 7702547 A SE7702547 A SE 7702547A SE 437832 B SE437832 B SE 437832B
- Authority
- SE
- Sweden
- Prior art keywords
- hydroxy
- cefem
- disubstituted
- preparing
- procedure
- Prior art date
Links
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 3
- 125000003282 alkyl amino group Chemical group 0.000 abstract 2
- 125000002947 alkylene group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
- 229930186147 Cephalosporin Natural products 0.000 abstract 1
- QPFYXYFORQJZEC-FOCLMDBBSA-N Phenazopyridine Chemical group NC1=NC(N)=CC=C1\N=N\C1=CC=CC=C1 QPFYXYFORQJZEC-FOCLMDBBSA-N 0.000 abstract 1
- 125000004423 acyloxy group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 229940124587 cephalosporin Drugs 0.000 abstract 1
- -1 cephalosporin compounds Chemical class 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229910052736 halogen Chemical group 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229940070891 pyridium Drugs 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/40—Unsubstituted amino or imino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/50—Nitrogen atoms bound to hetero atoms
- C07D277/52—Nitrogen atoms bound to hetero atoms to sulfur atoms, e.g. sulfonamides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9425/76A GB1575803A (en) | 1976-03-09 | 1976-03-09 | 3,7 disubstituted 3 cephem 4 carboxylic acid compounds andprocesses for the preparation thereof |
| GB4114576 | 1976-10-04 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE7702547L SE7702547L (sv) | 1977-09-10 |
| SE437832B true SE437832B (sv) | 1985-03-18 |
Family
ID=26242927
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7702547A SE437832B (sv) | 1976-03-09 | 1977-03-07 | Forfarande for framstellning av 3,7-disubstituerade-3-cefem-4-karboxylsyraforeningar |
| SE8302027A SE454988B (sv) | 1976-03-09 | 1983-04-12 | (2 ev. sub. amino -1,3-tiazol-5-yl)-glyoxylsyra derivat till anvendning som mellanprodukt till motsvarande cefalosporinsyror |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8302027A SE454988B (sv) | 1976-03-09 | 1983-04-12 | (2 ev. sub. amino -1,3-tiazol-5-yl)-glyoxylsyra derivat till anvendning som mellanprodukt till motsvarande cefalosporinsyror |
Country Status (10)
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL69246A (en) * | 1982-08-07 | 1986-07-31 | Tanabe Seiyaku Co | 7-((2-aminothiazolyl-2-pyrrolidonyl or(piperidonyl)-oxyimino)acetamido)cephem carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4093803A (en) * | 1971-05-14 | 1978-06-06 | Glaxo Laboratories Limited | 7β-[2-Etherified oximino-2-(thienyl-, furyl- or pyridylacetamido)] cephalosporins |
| GB1399086A (en) * | 1971-05-14 | 1975-06-25 | Glaxo Lab Ltd | Cephalosporin compounds |
| SE417968B (sv) * | 1972-10-20 | 1981-04-27 | Fujisawa Pharmaceutical Co | Forfarande for framstellning av penamderivat |
| US4113940A (en) * | 1973-03-15 | 1978-09-12 | Fujisawa Pharmaceutical Co., Ltd. | 7-amino 2-lower alkyl-2 or 3-cephem-4-carboxylic acid derivatives and processes for preparation thereof |
| JPS5119765A (en) * | 1974-08-09 | 1976-02-17 | Takeda Chemical Industries Ltd | Aminochiazoorujudotaino seizoho |
| DK154939C (da) * | 1974-12-19 | 1989-06-12 | Takeda Chemical Industries Ltd | Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf |
| US4298606A (en) * | 1974-12-19 | 1981-11-03 | Takeda Chemical Industries, Ltd. | Thiazolylacetamido compounds |
| GR63088B (en) * | 1976-04-14 | 1979-08-09 | Takeda Chemical Industries Ltd | Preparation process of novel cephalosporins |
-
1977
- 1977-03-01 IE IE439/77A patent/IE44888B1/en not_active IP Right Cessation
- 1977-03-04 CA CA000273202A patent/CA1218054A/en not_active Expired
- 1977-03-07 SE SE7702547A patent/SE437832B/xx not_active IP Right Cessation
- 1977-03-07 HU HU77FU363A patent/HU176455B/hu unknown
- 1977-03-07 HU HU77FU349A patent/HU179016B/hu not_active IP Right Cessation
- 1977-03-07 AR AR266766A patent/AR218241A1/es active
- 1977-03-07 MX MX775517U patent/MX4658E/es unknown
- 1977-03-08 ES ES456625A patent/ES456625A1/es not_active Expired
- 1977-03-08 DK DK101477A patent/DK168863B1/da not_active IP Right Cessation
- 1977-03-09 DE DE19772760288 patent/DE2760288A1/de active Pending
-
1978
- 1978-03-07 ES ES467635A patent/ES467635A1/es not_active Expired
- 1978-03-27 AR AR271539A patent/AR222010A1/es active
- 1978-12-16 ES ES476075A patent/ES476075A1/es not_active Expired
- 1978-12-16 ES ES476076A patent/ES476076A1/es not_active Expired
- 1978-12-16 ES ES476077A patent/ES476077A1/es not_active Expired
-
1983
- 1983-04-12 SE SE8302027A patent/SE454988B/sv not_active IP Right Cessation
-
1984
- 1984-01-18 US US06/571,700 patent/US4560765A/en not_active Expired - Lifetime
-
1991
- 1991-07-25 DK DK911396A patent/DK139691D0/da not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DK139691A (da) | 1991-07-25 |
| DK168863B1 (da) | 1994-06-27 |
| DE2760288A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1985-05-09 |
| IE44888L (en) | 1977-09-09 |
| SE8302027D0 (sv) | 1983-04-12 |
| CA1218054A (en) | 1987-02-17 |
| DK139691D0 (da) | 1991-07-25 |
| MX4658E (es) | 1982-07-19 |
| AR218241A1 (es) | 1980-05-30 |
| HU179016B (en) | 1982-08-28 |
| US4560765A (en) | 1985-12-24 |
| IE44888B1 (en) | 1982-05-05 |
| HU176455B (en) | 1981-03-28 |
| SE454988B (sv) | 1988-06-13 |
| ES476075A1 (es) | 1979-05-16 |
| ES476076A1 (es) | 1979-05-16 |
| SE8302027L (sv) | 1983-04-12 |
| ES476077A1 (es) | 1979-05-16 |
| ES467635A1 (es) | 1979-09-01 |
| DK101477A (da) | 1977-09-10 |
| ES456625A1 (es) | 1978-07-16 |
| SE7702547L (sv) | 1977-09-10 |
| AR222010A1 (es) | 1981-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO820264L (no) | Fremgangsmaate for fremstilling av 2-penemforbindelser | |
| DE3869173D1 (de) | Amino 5,6,7,8-tetrahydronaphtho(2,3b)furanderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel. | |
| ES8401961A1 (es) | Procedimiento para la preparacion de nuevas n-(4-indolil-piperidino-alcohil-bencimidazolonas sustituidas. | |
| ES517393A0 (es) | Un procedimiento de preparacion de nuevas cefalosporinas. | |
| SE7813352L (sv) | Nya 2-pyrrolidonforeningar och forfarande for framstellning av desamma | |
| ES508343A0 (es) | "procedimiento para la preparacion de nuevas pirimido (5,4-d) pirimidinas trisustituidas". | |
| SE8204418D0 (sv) | N-imidazolyl-derivat av 1,2,3,4-tetrahydronaftalen, indan och 2-substituerad-1-kroman, och forfarande for deras framstellning | |
| DE3367215D1 (en) | Pyridobenzodiazepinones, process for their preparation and pharmaceutical compositions containing them | |
| IL61687A (en) | (benzothiazole-2-yl-thio)-phenylpropionic acid derivatives,pharmaceutical formulations containing them and a process for their preparation | |
| SE437832B (sv) | Forfarande for framstellning av 3,7-disubstituerade-3-cefem-4-karboxylsyraforeningar | |
| ATE92927T1 (de) | 1-carboxy-1-vinyloxyiminoaminothiazolcephalosporin-derivate und deren herstellung. | |
| SE8301785L (sv) | Sett att framstella 2-tiofen-ettiksyraderivat och mellanprodukter erforderliga for deras framstellning | |
| ATE753T1 (de) | Neue substituierte 2-phen ylamino-1,3-tetrahydropyrimidine-(2), deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zur herstellung derselben. | |
| SE7909157L (sv) | Forfarande for framstellning av cyklo-1,3,2-oxazafosforylderivat | |
| DE3173642D1 (en) | Cephalosporin derivatives, process for their preparation, pharmaceutical compositions containing them and intermediates for their preparation | |
| AU547599B2 (en) | Tricyclic compounds | |
| ES454265A1 (es) | Un procedimiento para la obtencion de nuevas cefalosporinas. | |
| SE7905025L (sv) | Tereftalsyramonoamidderivat, forfarande for framstellning derav och antiallergiskt medel | |
| GB2001068A (en) | Penicillin and cephalosporin preparation | |
| FI882667A7 (fi) | Foerfarande foer framstaellning av antibakteriska vid 7-staellningen substituerade 1-cyklopropyl-6-fluor -1,4-dihydro-4-oxo-1,8-naftyridin-3-karboxylsyror. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAL | Patent in force |
Ref document number: 7702547-6 Format of ref document f/p: F |
|
| NUG | Patent has lapsed |
Ref document number: 7702547-6 Format of ref document f/p: F |